Clinical trial
Acitretin Plasma Levels Under Hemodialysis
NCT00488384 · Günther Hofbauer, Other · Withdrawn
Key facts
| NCT number | NCT00488384 |
|---|---|
| Title | Acitretin Plasma Levels Under Hemodialysis |
| Official title | Acitretin Plasma Levels Under Hemodialysis |
| Lead sponsor | Günther Hofbauer, Other |
| Collaborators | University of Zurich |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Carcinoma, Squamous Cell |
| Intervention type | Drug |
| Interventions | Chemopreventive application (Acitretin) |
| Enrollment | 0 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2014 |
| Completion | Jun 1, 2018 |
| First posted | Jun 20, 2007 |
| Last update posted | Jul 19, 2018 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: